Alphs LD - Search Results

1

Impaired Wisconsin Card Sort performance in schizophrenia may reflect motivational deficits.

Summerfelt AT, Alphs LD, Funderburk FR, Strauss ME, Wagman AM. Summerfelt AT, et al. Among authors: alphs ld. Arch Gen Psychiatry. 1991 Mar;48(3):282-3. doi: 10.1001/archpsyc.1991.01810270094019. Arch Gen Psychiatry. 1991. PMID: 1996924 No abstract available.

2

Disengagement of attention in chronic schizophrenia.

Strauss ME, Alphs L, Boekamp J. Strauss ME, et al. Psychiatry Res. 1992 Jul;43(1):87-92. doi: 10.1016/0165-1781(92)90144-r. Psychiatry Res. 1992. PMID: 1438619

3

Reduction of perseverative errors in patients with schizophrenia using monetary feedback.

Summerfelt AT, Alphs LD, Wagman AM, Funderburk FR, Hierholzer RM, Strauss ME. Summerfelt AT, et al. Among authors: alphs ld. J Abnorm Psychol. 1991 Nov;100(4):613-6. doi: 10.1037//0021-843x.100.4.613. J Abnorm Psychol. 1991. PMID: 1757677

4

The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia.

Alphs LD, Summerfelt A, Lann H, Muller RJ. Alphs LD, et al. Psychopharmacol Bull. 1989;25(2):159-63. Psychopharmacol Bull. 1989. PMID: 2602512 No abstract available.

5

Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies.

Tamminga CA, Littman RL, Alphs LD, Chase TN, Thaker GK, Wagman AM. Tamminga CA, et al. Among authors: alphs ld. Psychopharmacology (Berl). 1986;88(3):387-91. doi: 10.1007/BF00180843. Psychopharmacology (Berl). 1986. PMID: 3083460

6

Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine.

Tamminga CA, Gotts MD, Thaker GK, Alphs LD, Foster NL. Tamminga CA, et al. Among authors: alphs ld. Arch Gen Psychiatry. 1986 Apr;43(4):398-402. doi: 10.1001/archpsyc.1986.01800040108015. Arch Gen Psychiatry. 1986. PMID: 2869745 Clinical Trial.

7

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S; International Suicide Prevention Trial Study Group. Meltzer HY, et al. Arch Gen Psychiatry. 2003 Jan;60(1):82-91. doi: 10.1001/archpsyc.60.1.82. Arch Gen Psychiatry. 2003. PMID: 12511175 Clinical Trial.

8

Increased numbers of CD5+ B lymphocytes in schizophrenic patients.

McAllister CG, Rapaport MH, Pickar D, Podruchny TA, Christison G, Alphs LD, Paul SM. McAllister CG, et al. Among authors: alphs ld. Arch Gen Psychiatry. 1989 Oct;46(10):890-4. doi: 10.1001/archpsyc.1989.01810100032006. Arch Gen Psychiatry. 1989. PMID: 2478093

9

Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome.

Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT. Tamminga CA, et al. Among authors: alphs ld. Arch Gen Psychiatry. 1992 Jul;49(7):522-30. doi: 10.1001/archpsyc.1992.01820070016003. Arch Gen Psychiatry. 1992. PMID: 1627043

10

The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr. Kirkpatrick B, et al. Among authors: alphs ld. Psychiatry Res. 1989 Nov;30(2):119-23. doi: 10.1016/0165-1781(89)90153-4. Psychiatry Res. 1989. PMID: 2616682

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters